Loss of Caspase-Activated DNase Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice

被引:6
作者
Chao, Meng-Lin [1 ,3 ]
Guo, Junhong [2 ,3 ,4 ]
Cheng, Wen-Lin [2 ,3 ,4 ]
Zhu, Xue-Yong [2 ,3 ,4 ]
She, Zhi-Gang [2 ,3 ,4 ]
Huang, Zan [5 ]
Ji, Yong [1 ]
Li, Hongliang [2 ,3 ,4 ]
机构
[1] Nanjing Med Univ, Sch Pharm, Key Lab Cardiovasc & Cerebrovasc Med, 101 Longmian Rd, Nanjing 211166, Jiangsu, Peoples R China
[2] Wuhan Univ, Renmin Hosp, Dept Cardiol, 115 Donghu Rd, Wuhan 430071, Peoples R China
[3] Wuhan Univ, Inst Model Anim, 115 Donghu Rd, Wuhan 430071, Peoples R China
[4] Wuhan Univ, Sch Med, Med Res Inst, 115 Donghu Rd, Wuhan 430071, Peoples R China
[5] Wuhan Univ, Coll Life Sci, Wuhan, Peoples R China
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2016年 / 5卷 / 12期
基金
中国国家自然科学基金;
关键词
apoptosis; atherosclerosis; caspase-activated DNase; inflammation; macrophage; PATHOLOGICAL CARDIAC-HYPERTROPHY; KAPPA-B; HEMATOPOIETIC STEM; INFLAMMATION; MACROPHAGES; INHIBITION; APOPTOSIS; CELLS; ATHEROGENESIS; REGULATOR;
D O I
10.1161/JAHA.116.004362
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Atherosclerosis is a chronic disease that is closely related to inflammation and macrophage apoptosis, which leads to secondary necrosis and proinflammatory responses in advanced lesions. Caspase-activated DNase (CAD) is a double-strand specific endonuclease that leads to the subsequent degradation of chromosome DNA during apoptosis. However, whether CAD is involved in the progression of atherosclerosis remains elusive. Methods and Results-CAD(-/-) ApoE(-/-) and ApoE(-/-) littermates were fed a high-fat diet for 28 weeks to develop atherosclerosis. Human specimens were collected from coronary heart disease (CHD) patients who were not suitable for transplantation. CAD expression was increased in the atheromatous lesions of CHD patients and high-fat diet-treated ApoE-deficient mice. Further investigation demonstrated that CAD deficiency inhibited high-fat diet-induced atherosclerosis, as evidenced by decreased atherosclerotic plaques, inhibited inflammatory response, and macrophage apoptosis, as well as enhanced stability of plaques in CAD(-/-) ApoE(-/-) mice compared to the ApoE(-/-) controls. Bone marrow transplantation verified the effect of CAD on atherosclerosis from macrophages. Mechanically, the decrease in the phosphorylated levels of mitogen-activated protein kinase (MAPK) kinase/extracellular signal-regulated kinase 1 and 2 (MEK-ERK1/2) that resulted from CAD knockout and the activation of nuclear factor kappa B signaling mediated by CAD stimulation that was suppressed by inhibiting ERK1/2 phosphorylation revealed the potential association between the role of CAD in atherosclerosis and the MAPK signaling pathway. Conclusions-In conclusion, CAD deficiency protects against atherosclerosis through inhibiting inflammation and macrophage apoptosis, which is partially through inactivation of the MEK-ERK1/2 signaling pathway. This finding provides a promising therapeutic target for treating atherosclerosis.
引用
收藏
页数:18
相关论文
共 42 条
[1]   Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion [J].
Brand, K ;
Page, S ;
Rogler, G ;
Bartsch, A ;
Brandl, R ;
Knuechel, R ;
Page, M ;
Kaltschmidt, C ;
Baeuerle, PA ;
Neumeier, D .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (07) :1715-1722
[2]   Regulator of G-protein signalling 5 protects against atherosclerosis in apolipoprotein E-deficient mice [J].
Cheng, Wen-Lin ;
Wang, Pi-Xiao ;
Wang, Tao ;
Zhang, Yan ;
Du, Cheng ;
Li, Hongliang ;
Ji, Yong .
BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (23) :5676-5689
[3]   The emerging role of vascular smooth muscle cell apoptosis in atherosclerosis and plaque stability [J].
Clarke, Murray ;
Bennett, Martin .
AMERICAN JOURNAL OF NEPHROLOGY, 2006, 26 (06) :531-535
[4]   Macrophage Phenotypes and Their Modulation in Atherosclerosis [J].
De Paoli, Federica ;
Staels, Bart ;
Chinetti-Gbaguidi, Giulia .
CIRCULATION JOURNAL, 2014, 78 (08) :1775-1781
[5]   Suppressor of IKKε is an essential negative regulator of pathological cardiac hypertrophy [J].
Deng, Ke-Qiong ;
Wang, Aibing ;
Ji, Yan-Xiao ;
Zhang, Xiao-Jing ;
Fang, Jing ;
Zhang, Yan ;
Zhang, Peng ;
Jiang, Xi ;
Gao, Lu ;
Zhu, Xue-Yong ;
Zhao, Yichao ;
Gao, Lingchen ;
Yang, Qinglin ;
Zhu, Xue-Hai ;
Wei, Xiang ;
Pu, Jun ;
Li, Hongliang .
NATURE COMMUNICATIONS, 2016, 7
[6]   A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD [J].
Enari, M ;
Sakahira, H ;
Yokoyama, H ;
Okawa, K ;
Iwamatsu, A ;
Nagata, S .
NATURE, 1998, 391 (6662) :43-50
[7]   Novel Role for Caspase-Activated DNase in the Regulation of Pathological Cardiac Hypertrophy [J].
Gao, Lu ;
Huang, Kun ;
Jiang, Ding-Sheng ;
Liu, Xiaoxiong ;
Huang, Dan ;
Li, Hongliang ;
Zhang, Xiao-Dong ;
Huang, Kai .
HYPERTENSION, 2015, 65 (04) :871-+
[8]   Atherosclerosis: The road ahead [J].
Glass, CK ;
Witztum, JL .
CELL, 2001, 104 (04) :503-516
[9]   Shared principles in NF-κB signaling [J].
Hayden, Matthew S. ;
Ghosh, Sankar .
CELL, 2008, 132 (03) :344-362
[10]   Oxidized low-density lipoproteins: What is understood and what remains to be clarified [J].
Itabe, H .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2003, 26 (01) :1-9